These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 12670397)

  • 1. Lipid phosphatases in the regulation of T cell activation: living up to their PTEN-tial.
    Seminario MC; Wange RL
    Immunol Rev; 2003 Apr; 192():80-97. PubMed ID: 12670397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTEN permits acute increases in D3-phosphoinositide levels following TCR stimulation but inhibits distal signaling events by reducing the basal activity of Akt.
    Seminario MC; Precht P; Bunnell SC; Warren SE; Morris CM; Taub D; Wange RL
    Eur J Immunol; 2004 Nov; 34(11):3165-75. PubMed ID: 15468057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that SHIP-1 contributes to phosphatidylinositol 3,4,5-trisphosphate metabolism in T lymphocytes and can regulate novel phosphoinositide 3-kinase effectors.
    Freeburn RW; Wright KL; Burgess SJ; Astoul E; Cantrell DA; Ward SG
    J Immunol; 2002 Nov; 169(10):5441-50. PubMed ID: 12421919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signaling pathways of D3-phosphoinositide-binding kinases in T cells and their regulation by PTEN.
    Seminario MC; Wange RL
    Semin Immunol; 2002 Feb; 14(1):27-36. PubMed ID: 11884228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deficiency of PTEN in Jurkat T cells causes constitutive localization of Itk to the plasma membrane and hyperresponsiveness to CD3 stimulation.
    Shan X; Czar MJ; Bunnell SC; Liu P; Liu Y; Schwartzberg PL; Wange RL
    Mol Cell Biol; 2000 Sep; 20(18):6945-57. PubMed ID: 10958690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor β (TGF-β) receptor signaling regulates kinase networks and phosphatidylinositol metabolism during T-cell activation.
    Cattley RT; Lee M; Boggess WC; Hawse WF
    J Biol Chem; 2020 Jun; 295(24):8236-8251. PubMed ID: 32358062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTEN and myotubularin phosphatases: from 3-phosphoinositide dephosphorylation to disease.
    Wishart MJ; Dixon JE
    Trends Cell Biol; 2002 Dec; 12(12):579-85. PubMed ID: 12495846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate.
    Maehama T; Dixon JE
    J Biol Chem; 1998 May; 273(22):13375-8. PubMed ID: 9593664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTEN and Other PtdIns(3,4,5)P
    Csolle MP; Ooms LM; Papa A; Mitchell CA
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33276499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SHIP-2 and PTEN are expressed and active in vascular smooth muscle cell nuclei, but only SHIP-2 is associated with nuclear speckles.
    Déléris P; Bacqueville D; Gayral S; Carrez L; Salles JP; Perret B; Breton-Douillon M
    J Biol Chem; 2003 Oct; 278(40):38884-91. PubMed ID: 12847108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonism of PI 3-kinase-dependent signalling pathways by the tumour suppressor protein, PTEN.
    Downes CP; Bennett D; McConnachie G; Leslie NR; Pass I; MacPhee C; Patel L; Gray A
    Biochem Soc Trans; 2001 Nov; 29(Pt 6):846-51. PubMed ID: 11709086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphoinositide lipid phosphatases: natural regulators of phosphoinositide 3-kinase signaling in T lymphocytes.
    Harris SJ; Parry RV; Westwick J; Ward SG
    J Biol Chem; 2008 Feb; 283(5):2465-9. PubMed ID: 18073217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative feedback regulation of the tumor suppressor PTEN by phosphoinositide-induced serine phosphorylation.
    Birle D; Bottini N; Williams S; Huynh H; deBelle I; Adamson E; Mustelin T
    J Immunol; 2002 Jul; 169(1):286-91. PubMed ID: 12077256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The INPP4B paradox: Like PTEN, but different.
    Hamila SA; Ooms LM; Rodgers SJ; Mitchell CA
    Adv Biol Regul; 2021 Dec; 82():100817. PubMed ID: 34216856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of phosphoinositide metabolism, Akt phosphorylation, and glucose transport by PTEN (phosphatase and tensin homolog deleted on chromosome 10) in 3T3-L1 adipocytes.
    Ono H; Katagiri H; Funaki M; Anai M; Inukai K; Fukushima Y; Sakoda H; Ogihara T; Onishi Y; Fujishiro M; Kikuchi M; Oka Y; Asano T
    Mol Endocrinol; 2001 Aug; 15(8):1411-22. PubMed ID: 11463863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease.
    Oudit GY; Sun H; Kerfant BG; Crackower MA; Penninger JM; Backx PH
    J Mol Cell Cardiol; 2004 Aug; 37(2):449-71. PubMed ID: 15276015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of PI3K effector signalling in cancer by the phosphoinositide phosphatases.
    Rodgers SJ; Ferguson DT; Mitchell CA; Ooms LM
    Biosci Rep; 2017 Feb; 37(1):. PubMed ID: 28082369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tumor suppressor PTEN regulates T cell survival and antigen receptor signaling by acting as a phosphatidylinositol 3-phosphatase.
    Wang X; Gjörloff-Wingren A; Saxena M; Pathan N; Reed JC; Mustelin T
    J Immunol; 2000 Feb; 164(4):1934-9. PubMed ID: 10657643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTEN expression causes feedback upregulation of insulin receptor substrate 2.
    Simpson L; Li J; Liaw D; Hennessy I; Oliner J; Christians F; Parsons R
    Mol Cell Biol; 2001 Jun; 21(12):3947-58. PubMed ID: 11359902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PI 3-kinases and PTEN: how opposites chemoattract.
    Comer FI; Parent CA
    Cell; 2002 May; 109(5):541-4. PubMed ID: 12062096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.